Aequor, Inc

Aequor - pronounced Acorn without the "n"- means "The Sea" in Latin. Aequor's Founder discovered new chemicals in the ocean that are more potent and less toxic than anything known to kill bacteria and fungi - including the antimicrobial resistant (AMR) Superbugs. PRODUCTS: Our platform includes "green" chemicals and products containing them for B2B sales and licensing-Available now: 25 specialty chemicals - EPA/TSCA-approved -ingredients for consumer products to replace harmful biocides -proprietary formulations - sprays, washes, paints, coatings, etc-treatments for improving algae and yeast biomass production processes up to 40% in half the time for biofuels and renewable co-products -surface cleaners -water treatments -Pending EPA/FIFRA approval: 30 antimicrobials that are "green" and non-toxic for products and treatments making antibacterial, antifungal, antibiofilm and antifouling claims -Pending FDA approval : 30 new drug candidates The NIH offered Aequor free pre-clinical trials for as many new drug candidates we can deliver in half-kilo samples. The DOD offered the same for up to 5 new drug candidates. SERVICES Aequor offers microbial and biofilm testing, training and consulting to optimize customers' products; determine efficacy of third party products. UNMATCHED EXPERTISE Aequor's Founder Cynthia Burzell, Ph.D- Marine and Medical Microbiology - is considered a pioneer in Biofilms. She lectures internationally and offers educational training programs on biofilm and its impacts on the costs and operational inefficiencies in agro-industry, consumer, and healthcare sectors. UNMATCHED MODEL Aequor is a resident company at JLabs San Diego, raised $1.2M cash and is a Woman Owned Small Business, eligible for 5% of government contracts. For our in-house and virtual management team and updates, see our website. For further information: Marilyn Bruno, CEO - mbruno@aequorinc.com